1 year return (CAGR)
342.71%
Climb Bio Inc Exchange (NASDAQ, USD)
CLYM
10.25
-1.38 (-13.54%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
50.01%
5 year return (CAGR)
-11.18%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
506.01M
Price/Sales
-
Ent value
468.65M
Price/Book
2.11
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-13.01%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 9.88 |
| Daily high | 9.99 |
| Daily low | 8.70 |
| Daily Volume | 3.38M |
| All-time high | 28.61 |
| 1y analyst estimate | 27.57 |
| Beta | 0.10 |
| EPS (TTM) | -0.76 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 9 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CLYM | S&P500 | |
| Current price drop from All-time high | -64.17% | -3.00% |
| Highest price drop | -96.05% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -79.68% | -10.65% |
| Avg time to new high | 187 days | 12 days |
| Max time to new high | 1290 days | 1805 days |
News
